Klotho Neurosciences (KLTOW) Stock

Profile

Full Name:

Klotho Neurosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://www.klothoneuro.com

Description:

Klotho Neurosciences focuses on developing innovative therapies for neurodegenerative diseases, aiming to improve brain health and cognitive function through advanced research and biotechnology solutions.

Key Details

Price

$0.05

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

-50.76%

Annual Debt To Equity

1.14

Beta

1.36

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with KLTOW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.05
KLTOW price is $0.05

Price All-time High

$0.06
KLTOW price is currently -20.67% below its historical high of $0.06

Beta

1.36
KLTOW beta is 1.36

200-day SMA

$0.06
KLTOW price is currently -13.45% below its 200-day simple moving average

14-day RSI

10.00
KLTOW 14-day relative strength index is 10.00

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+0%
KLTOW annual revenue is up +0% over the past 3 years

Annual Net Income 3-Year Change

+46.03%
KLTOW annual net profit is up +46.03% over the past 3 years

Annual Operating Profit

-$574.37 K
KLTOW annual operaing income is -$574.37 thousand

Annual Operating Profit 3-Year Change

+48.21%
KLTOW annual operaing income is up +48.21% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

-50.76%
KLTOW annual return on equity is -50.76%

Annual ROA

-23.57%
KLTOW annual return on assets is -23.57%

Annual EBIT

-$574.23 K
KLTOW annual earnings before interest & taxes is -$574.23 thousand

Annual EBITDA

-$574.23 K
KLTOW annual earnings before interest, taxes, depreciation & amortization is -$574.23 thousand

Annual Interest Coverage Ratio

-23.57
KLTOW annual interest coverage ratio is -23.57

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

0.24
KLTOW annual current ratio is 0.24

Annual Total Assets

$2.54 M
KLTOW annual total assets is $2.54 million

Annual Current Assets

$329.54 K
KLTOW annual total current assets is $329.54 thousand

Annual Total Liabilities

$1.36 M
KLTOW annual total liabilities is $1.36 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-111.1%
KLTOW annual cash flow from operations is down -111.1% over the past 3 years

Annual CFI 3-Year Change

-100%
KLTOW annual cash flow from investing activities is down -100% over the past 3 years

Annual CFF 3-Year Change

+100%
KLTOW annual cash flow from financing activities is up +100% over the past 3 years

Annual CAPEX

$125.41 K
KLTOW annual capital expenditures is $125.41 thousand

Annual FCF

-$724.98 K
KLTOW annual free cash flow is -$724.98 thousand

Annual FCF 3-Year Change

-155.26%
KLTOW annual free cash flow is down -155.26% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Klotho Neurosciences?
  • What is the ticker symbol for Klotho Neurosciences?
  • Does Klotho Neurosciences pay dividends?
  • What sector is Klotho Neurosciences in?
  • What industry is Klotho Neurosciences in?
  • What country is Klotho Neurosciences based in?
  • Is Klotho Neurosciences in the S&P 500?
  • Is Klotho Neurosciences in the NASDAQ 100?
  • Is Klotho Neurosciences in the Dow Jones?
  • When does Klotho Neurosciences report earnings?

What is the primary business of Klotho Neurosciences?

Klotho Neurosciences focuses on developing innovative therapies for neurodegenerative diseases, aiming to improve brain health and cognitive function through advanced research and biotechnology solutions.

What is the ticker symbol for Klotho Neurosciences?

The ticker symbol for Klotho Neurosciences is NASDAQ:KLTOW

Does Klotho Neurosciences pay dividends?

No, Klotho Neurosciences does not pay dividends

What sector is Klotho Neurosciences in?

Klotho Neurosciences is in the Healthcare sector

What industry is Klotho Neurosciences in?

Klotho Neurosciences is in the Biotechnology industry

What country is Klotho Neurosciences based in?

Klotho Neurosciences is headquartered in United States

Is Klotho Neurosciences in the S&P 500?

No, Klotho Neurosciences is not included in the S&P 500 index

Is Klotho Neurosciences in the NASDAQ 100?

No, Klotho Neurosciences is not included in the NASDAQ 100 index

Is Klotho Neurosciences in the Dow Jones?

No, Klotho Neurosciences is not included in the Dow Jones index

When does Klotho Neurosciences report earnings?

The date for Klotho Neurosciences's next earnings report has not been announced yet